A Phase 1b/2 Study Evaluating the Activity of Tinengotinib (TT-00420) in Combination with Androgen Receptor Signaling Inhibitors (ARSIs) in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)
Clinical Trial Grant
Awarded By
Memorial Sloan-Kettering Cancer Center
Start Date
March 7, 2025
End Date
February 23, 2029
Awarded By
Memorial Sloan-Kettering Cancer Center
Start Date
March 7, 2025
End Date
February 23, 2029